160 related articles for article (PubMed ID: 37251916)
1. Metastatic insulinoma: exploration from clinicopathological signatures and genetic characteristics.
Zhang J; Jiang R; Hong X; Wu H; Han X; Wu W
Front Oncol; 2023; 13():1109330. PubMed ID: 37251916
[TBL] [Abstract][Full Text] [Related]
2. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.
Hackeng WM; Schelhaas W; Morsink FHM; Heidsma CM; van Eeden S; Valk GD; Vriens MR; Heaphy CM; Nieveen van Dijkum EJM; Offerhaus GJA; Dreijerink KMA; Brosens LAA
Endocr Pathol; 2020 Jun; 31(2):108-118. PubMed ID: 32103422
[TBL] [Abstract][Full Text] [Related]
3. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
Hong X; Qiao S; Li F; Wang W; Jiang R; Wu H; Chen H; Liu L; Peng J; Wang J; Jia C; Liang X; Dai H; Jiang J; Zhang T; Liao Q; Dai M; Cong L; Han X; Guo D; Liang Z; Li D; Zheng Z; Ye C; Li S; Zhao Y; Wu K; Wu W
Gut; 2020 May; 69(5):877-887. PubMed ID: 31462556
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.
Cao Y; Gao Z; Li L; Jiang X; Shan A; Cai J; Peng Y; Li Y; Jiang X; Huang X; Wang J; Wei Q; Qin G; Zhao J; Jin X; Liu L; Li Y; Wang W; Wang J; Ning G
Nat Commun; 2013; 4():2810. PubMed ID: 24326773
[TBL] [Abstract][Full Text] [Related]
6. Giant insulinoma: report of a case and review of published reports.
Ueda K; Taira T; Hakoda H; Nakata S; Okata S; Nagai T; Aoki S; Mishima H; Sako A; Maruyama T; Okumura M
Surg Case Rep; 2016 Dec; 2(1):136. PubMed ID: 27864816
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia.
Tarris G; Rouland A; Guillen K; Loffroy R; Lariotte AC; Rat P; Bouillet B; Andrianiaina H; Petit JM; Martin L
Front Endocrinol (Lausanne); 2023; 14():1125772. PubMed ID: 37234805
[TBL] [Abstract][Full Text] [Related]
8. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.
Lichtenauer UD; Di Dalmazi G; Slater EP; Wieland T; Kuebart A; Schmittfull A; Schwarzmayr T; Diener S; Wiese D; Thasler WE; Reincke M; Meitinger T; Schott M; Fassnacht M; Bartsch DK; Strom TM; Beuschlein F
J Clin Endocrinol Metab; 2015 May; 100(5):E776-82. PubMed ID: 25763608
[TBL] [Abstract][Full Text] [Related]
9. T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.
Irshad K; Jyotsna VP; Agarwal S; Chosdol K; Pal S; Deepak RK
Horm Metab Res; 2017 Jun; 49(6):452-456. PubMed ID: 28472826
[TBL] [Abstract][Full Text] [Related]
10. Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management.
Walker MP; Shenoy V; Metz DC; Stanley CA; Fraker D; Chandrasekhara V; Amaro A
BMC Endocr Disord; 2022 Dec; 22(1):310. PubMed ID: 36494838
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of patients with insulinomas: Result of 292 cases in a single institution.
Zhao YP; Zhan HX; Zhang TP; Cong L; Dai MH; Liao Q; Cai LX
J Surg Oncol; 2011 Feb; 103(2):169-74. PubMed ID: 21259252
[TBL] [Abstract][Full Text] [Related]
12. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and non-adhesive organ culture of insulinomas.
Hoem D; Jensen D; Steine S; Thorsen TE; Viste A; Molven A
Scand J Surg; 2008; 97(1):42-9. PubMed ID: 18450205
[TBL] [Abstract][Full Text] [Related]
15. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series.
Yu R; Nissen NN; Hendifar A; Tang L; Song YL; Chen YJ; Fan X
Pancreas; 2017 Jan; 46(1):48-56. PubMed ID: 27984486
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic options for metastatic malignant insulinomas.
de Herder WW; van Schaik E; Kwekkeboom D; Feelders RA
Clin Endocrinol (Oxf); 2011 Sep; 75(3):277-84. PubMed ID: 21649688
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections.
Crippa S; Zerbi A; Boninsegna L; Capitanio V; Partelli S; Balzano G; Pederzoli P; Di Carlo V; Falconi M
Arch Surg; 2012 Mar; 147(3):261-6. PubMed ID: 22430908
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival After Distal Pancreatectomy With Simultaneous Living-Donor Liver Transplant for Treatment of Pancreatic Insulinoma With Hepatic Metastasis: a Case Report.
Ohya Y; Hayashida S; Inomata Y
Exp Clin Transplant; 2021 Jan; 19(1):88-91. PubMed ID: 32967594
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of insulinoma.
Okabayashi T; Shima Y; Sumiyoshi T; Kozuki A; Ito S; Ogawa Y; Kobayashi M; Hanazaki K
World J Gastroenterol; 2013 Feb; 19(6):829-37. PubMed ID: 23430217
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020).
Walczak R; Kawalilak L; Griffin L
J Small Anim Pract; 2022 Mar; 63(3):227-233. PubMed ID: 34811734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
